However, TNF likely originates from tumor cells in MPE9 and non-specifically triggers NF-κB activation in any tumor type irrespective of its KRAS status and MPE competence, suggesting it functions as an autocrine growth factor across tumor types. The gene discussed is NFKB1; the disease is neoplasm.